NIH conference. Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy

Area of Science:

• Rheumatology and Immunology
• Neurology and Musculoskeletal Diseases

Background:

• Myositis syndromes, including polymyositis and dermatomyositis, are rare idiopathic chronic skeletal muscle inflammatory diseases.
• Despite over a century of description, their etiology and optimal treatments remain poorly understood due to disease rarity and heterogeneity.

Framework:

• Identification of myositis-specific autoantibodies (MSAs) targeting unique nuclear and cytoplasmic autoantigens.
• MSAs are increasingly recognized as valuable biomarkers in myositis.

Implementation:

• Utilizing MSAs to predict clinical manifestations, immunogenetic profiles, therapeutic responses, and patient prognosis.
• Characterizing the diversity and nature of MSAs and their specific target epitopes.

Implications:

• MSAs offer potential for identifying underlying causes and pathogenetic mechanisms of myositis.
• This knowledge can guide the development of more targeted and effective therapies for myositis patients.